Quartz Partners, LLC Supernus Pharmaceuticals, Inc. Transaction History
Quartz Partners, LLC
- $165 Billion
- Q1 2025
A detailed history of Quartz Partners, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Quartz Partners, LLC holds 19,848 shares of SUPN stock, worth $644,663. This represents 0.39% of its overall portfolio holdings.
Number of Shares
19,848
Previous 28,499
30.36%
Holding current value
$644,663
Previous $1.03 Billion
36.92%
% of portfolio
0.39%
Previous 0.63%
Shares
3 transactions
Others Institutions Holding SUPN
# of Institutions
304Shares Held
60.2MCall Options Held
8.8KPut Options Held
6.3K-
Black Rock Inc. New York, NY10.4MShares$338 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.16MShares$200 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$169 Million2.59% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.9MShares$94.3 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C32.7MShares$87.7 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.74B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...